Infectious Disease

 
Measles Outbreak Explained: Disease History, Vaccine Breakthrough and 2025 Resurgence
February 27, 2025

The 2025 measles outbreak in Texas has reignited discussion surrounding vaccine-preventable diseases and the importance of maintaining high immunization rates.

Measles Claims Life of Unvaccinated Texas Schoolchild, First US Fatality Reported Since 2015
February 27, 2025

A rural west Texas "undervaccinated" Mennonite community is the epicenter of the worst measles outbreak in the state in 30 years, the state health department reported.

Would you Know Measles if You Saw It?
February 27, 2025

A case of measles is a very rare diagnosis in the 21st century, but as MMR vaccination rates fall, the cases climb. Would you recognize the signs & symptoms?

This is Measles If You've Never Seen It
February 25, 2025

Here, the 5 key signs and symptoms that characterize measles in the order of appearance.

Oral Antiviral Candidate Shows Promise for RSV Treatment: Daily Dose
February 14, 2025

Your daily dose of the clinical news you may have missed.

COVID-19 Associated with Higher Long-Term Mortality Than Flu or RSV: New Data
February 03, 2025

Researchers found that COVID-19 had a higher long-term mortality than influenza and RSV in veterans—underscoring vaccination’s vital role.

Investigational RSV Antiviral Treatment Reduces Viral Load in Phase 2 Human Challenge Trial
January 30, 2025

The study of S-337395 showed an 88.9% reduction in RSV viral load and symptom improvement in the highest dose group, with no severe adverse events reported.

FDA Clears Cobas Liat Assay Panels for Point-of-Care Diagnosis of Sexually Transmitted Infections
January 23, 2025

These test panels allow clinicians to diagnose multiple STIs from a single specimen, with results available in about 20 minutes.

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment
January 20, 2025

The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning
January 08, 2025

The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.